Evidence map›Paper›PMID 24330864›Full record

ArticleActa neuropathologica communications2013

Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases.

Mee-Ohk Kim, Ignazio Cali, Abby Oehler, Jamie C Fong, Katherine Wong, Tricia See, Jonathan S Katz, Pierluigi Gambetti, Brianne M Bettcher, Stephen J Dearmond and 1 more

Open access · goldAbstract readCase ReportsComparative Study
In one paragraph

Article in Acta neuropathologica communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Two distinct conformers of PrPActa neuropathologica communications · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Genetic PrP Prion Diseases.Cold Spring Harbor perspectives in biology · 2018
    Review
  14. Prion disease.Handbook of clinical neurology · 2018
    Review
  15. Characterization of mutations inNeuropsychiatric disease and treatment · 2018
    Review
  16. Hereditary Human Prion Diseases: an Update.Molecular neurobiology · 2017
    Review
  17. Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Review
  18. Article
  19. Prion Diseases.Continuum (Minneapolis, Minn.) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Mee-Ohk Kim
Ignazio Cali
Abby Oehler
Jamie C Fong
Katherine Wong
Tricia See
Jonathan S Katz
Pierluigi Gambetti
Brianne M Bettcher
Stephen J Dearmond
Michael D GeschwindDepartment of Neurology, Memory and Aging Center, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA. mgeschwind@memory.ucsf.edu.
University of California, San Francisco · USUniversity Memory and Aging Center · USCalifornia Pacific Medical Center · USCase Western Reserve University · USUniversity of Campania "Luigi Vanvitelli" · IT

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
VIRAL DEGENERATIVE DEMENTING DISEASE IN AGING (SUPP)P01AG002132 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 1985 to 2024
$51.7M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
TRANSGENIC MODELS OF PRION DISEASES LINKED TO D178N MUTATIONP01AG014359 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI GAMBETTI, PIERLUIGI · 1997 to 2013
$22.2M
Predicting progression of human prion diseaseR01AG031189 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2008 to 2017
$5.7M
Replication mechanism of human prionsR01NS074317 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SAFAR, JIRI G., SUREWICZ, WITOLD K · 2011 to 2015
$2.6M
NCRR NIH HHS UL1 RR024131NIA NIH HHS AG14359NIA NIH HHS P01 AG02132NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG031189NINDS NIH HHS NS074317
6 · The paper itself

Abstract

A novel point mutation resulting in a glutamate-to-glycine substitution in PRNP at codon 200, E200G with codon 129 MV polymorphism (cis valine) and type 2 PrPSc was identified in a patient with a prolonged disease course leading to pathology-proven Jakob-Creutzfeldt disease. Despite the same codon as the most common genetic form of human PRNP mutation, E200K, this novel mutation (E200G) presented with a different clinical and pathological phenotype, including prolonged duration, large vacuoles, no vacuolation in the hippocampus, severe neuronal loss in the thalamus, mild cerebellar involvement, and abundant punctate linear and curvilinear deposition of PrPSc in synaptic boutons and axonal terminals along the dendrites.

Indexed as

Point MutationBrainCreutzfeldt-Jakob SyndromeFatal OutcomeFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMiddle AgedNeuropsychological TestsPedigreePrionsPrions

Identifiers

PMID24330864
PMCPMC3880091
OpenAlexW2114728613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.